JPS6317434B2 - - Google Patents
Info
- Publication number
- JPS6317434B2 JPS6317434B2 JP10770879A JP10770879A JPS6317434B2 JP S6317434 B2 JPS6317434 B2 JP S6317434B2 JP 10770879 A JP10770879 A JP 10770879A JP 10770879 A JP10770879 A JP 10770879A JP S6317434 B2 JPS6317434 B2 JP S6317434B2
- Authority
- JP
- Japan
- Prior art keywords
- trna
- enzyme
- guanosine
- loop
- methyltransferase
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 108020004566 Transfer RNA Proteins 0.000 claims description 38
- NYHBQMYGNKIUIF-UUOKFMHZSA-N Guanosine Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O NYHBQMYGNKIUIF-UUOKFMHZSA-N 0.000 claims description 26
- MIKUYHXYGGJMLM-GIMIYPNGSA-N Crotonoside Natural products C1=NC2=C(N)NC(=O)N=C2N1[C@H]1O[C@@H](CO)[C@H](O)[C@@H]1O MIKUYHXYGGJMLM-GIMIYPNGSA-N 0.000 claims description 13
- NYHBQMYGNKIUIF-UHFFFAOYSA-N D-guanosine Natural products C1=2NC(N)=NC(=O)C=2N=CN1C1OC(CO)C(O)C1O NYHBQMYGNKIUIF-UHFFFAOYSA-N 0.000 claims description 13
- 229940029575 guanosine Drugs 0.000 claims description 13
- 125000003729 nucleotide group Chemical group 0.000 claims description 13
- 239000002773 nucleotide Substances 0.000 claims description 12
- 108060004795 Methyltransferase Proteins 0.000 claims description 11
- 102000016397 Methyltransferase Human genes 0.000 claims description 11
- 230000000694 effects Effects 0.000 claims description 9
- 239000000758 substrate Substances 0.000 claims description 7
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 6
- 238000002523 gelfiltration Methods 0.000 claims description 5
- 238000000034 method Methods 0.000 claims description 5
- 230000007704 transition Effects 0.000 claims description 3
- 238000012546 transfer Methods 0.000 claims description 2
- 108091032973 (ribonucleotides)n+m Proteins 0.000 claims 1
- 102000004190 Enzymes Human genes 0.000 description 34
- 108090000790 Enzymes Proteins 0.000 description 34
- 241000588724 Escherichia coli Species 0.000 description 13
- 239000000243 solution Substances 0.000 description 13
- 125000001360 methionine group Chemical group N[C@@H](CCSC)C(=O)* 0.000 description 12
- 239000000872 buffer Substances 0.000 description 9
- 230000011987 methylation Effects 0.000 description 8
- 238000007069 methylation reaction Methods 0.000 description 8
- OVYNGSFVYRPRCG-UHFFFAOYSA-N 2'-O-Methylguanosine Natural products COC1C(O)C(CO)OC1N1C(NC(N)=NC2=O)=C2N=C1 OVYNGSFVYRPRCG-UHFFFAOYSA-N 0.000 description 6
- OVYNGSFVYRPRCG-KQYNXXCUSA-N 2'-O-methylguanosine Chemical compound CO[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(N=C(N)NC2=O)=C2N=C1 OVYNGSFVYRPRCG-KQYNXXCUSA-N 0.000 description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
- 239000006228 supernatant Substances 0.000 description 6
- 241000894006 Bacteria Species 0.000 description 5
- 238000004440 column chromatography Methods 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 239000002244 precipitate Substances 0.000 description 5
- GUBGYTABKSRVRQ-WFVLMXAXSA-N DEAE-cellulose Chemical compound OC1C(O)C(O)C(CO)O[C@H]1O[C@@H]1C(CO)OC(O)C(O)C1O GUBGYTABKSRVRQ-WFVLMXAXSA-N 0.000 description 4
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 4
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 4
- 229920005654 Sephadex Polymers 0.000 description 4
- 239000012507 Sephadex™ Substances 0.000 description 4
- 229940041514 candida albicans extract Drugs 0.000 description 4
- 239000012138 yeast extract Substances 0.000 description 4
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 3
- 101100377299 Arabidopsis thaliana ZHD13 gene Proteins 0.000 description 3
- 108010083644 Ribonucleases Proteins 0.000 description 3
- 102000006382 Ribonucleases Human genes 0.000 description 3
- MEFKEPWMEQBLKI-AIRLBKTGSA-N S-adenosyl-L-methioninate Chemical compound O[C@@H]1[C@H](O)[C@@H](C[S+](CC[C@H](N)C([O-])=O)C)O[C@H]1N1C2=NC=NC(N)=C2N=C1 MEFKEPWMEQBLKI-AIRLBKTGSA-N 0.000 description 3
- 239000012506 Sephacryl® Substances 0.000 description 3
- 241000589499 Thermus thermophilus Species 0.000 description 3
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 3
- 239000001913 cellulose Substances 0.000 description 3
- 229920002678 cellulose Polymers 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 3
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 2
- 241000283690 Bos taurus Species 0.000 description 2
- 102000016911 Deoxyribonucleases Human genes 0.000 description 2
- 108010053770 Deoxyribonucleases Proteins 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 2
- 239000001888 Peptone Substances 0.000 description 2
- 108010080698 Peptones Proteins 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
- 241000589596 Thermus Species 0.000 description 2
- 241000051160 Thermus thermophilus HB27 Species 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 239000007853 buffer solution Substances 0.000 description 2
- RMRCNWBMXRMIRW-BYFNXCQMSA-M cyanocobalamin Chemical compound N#C[Co+]N([C@]1([H])[C@H](CC(N)=O)[C@]\2(CCC(=O)NC[C@H](C)OP(O)(=O)OC3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)C)C/2=C(C)\C([C@H](C/2(C)C)CCC(N)=O)=N\C\2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O RMRCNWBMXRMIRW-BYFNXCQMSA-M 0.000 description 2
- 239000007857 degradation product Substances 0.000 description 2
- 238000010828 elution Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 108010079502 exoribonuclease T Proteins 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 238000005194 fractionation Methods 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 2
- 229910017053 inorganic salt Inorganic materials 0.000 description 2
- 229910001629 magnesium chloride Inorganic materials 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 229960004452 methionine Drugs 0.000 description 2
- PXQPEWDEAKTCGB-UHFFFAOYSA-N orotic acid Chemical compound OC(=O)C1=CC(=O)NC(=O)N1 PXQPEWDEAKTCGB-UHFFFAOYSA-N 0.000 description 2
- 235000019319 peptone Nutrition 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- PFNFFQXMRSDOHW-UHFFFAOYSA-N spermine Chemical compound NCCCNCCCCNCCCN PFNFFQXMRSDOHW-UHFFFAOYSA-N 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- 108010033073 tRNA (guanine(10)-N(2))-dimethyltransferase Proteins 0.000 description 2
- WWJZWCUNLNYYAU-UHFFFAOYSA-N temephos Chemical compound C1=CC(OP(=S)(OC)OC)=CC=C1SC1=CC=C(OP(=S)(OC)OC)C=C1 WWJZWCUNLNYYAU-UHFFFAOYSA-N 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- JVIPLYCGEZUBIO-UHFFFAOYSA-N 2-(4-fluorophenyl)-1,3-dioxoisoindole-5-carboxylic acid Chemical compound O=C1C2=CC(C(=O)O)=CC=C2C(=O)N1C1=CC=C(F)C=C1 JVIPLYCGEZUBIO-UHFFFAOYSA-N 0.000 description 1
- ZKHQWZAMYRWXGA-KQYNXXCUSA-J ATP(4-) Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)[C@H]1O ZKHQWZAMYRWXGA-KQYNXXCUSA-J 0.000 description 1
- ZKHQWZAMYRWXGA-UHFFFAOYSA-N Adenosine triphosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)C(O)C1O ZKHQWZAMYRWXGA-UHFFFAOYSA-N 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- HMFHBZSHGGEWLO-SOOFDHNKSA-N D-ribofuranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H]1O HMFHBZSHGGEWLO-SOOFDHNKSA-N 0.000 description 1
- 229920001425 Diethylaminoethyl cellulose Polymers 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 108091034117 Oligonucleotide Proteins 0.000 description 1
- 102000004861 Phosphoric Diester Hydrolases Human genes 0.000 description 1
- 108090001050 Phosphoric Diester Hydrolases Proteins 0.000 description 1
- 102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 description 1
- 108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 description 1
- 102000055027 Protein Methyltransferases Human genes 0.000 description 1
- 108700040121 Protein Methyltransferases Proteins 0.000 description 1
- PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 description 1
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 229960001570 ademetionine Drugs 0.000 description 1
- HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 235000011148 calcium chloride Nutrition 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 229960002104 cyanocobalamin Drugs 0.000 description 1
- 235000000639 cyanocobalamin Nutrition 0.000 description 1
- 239000011666 cyanocobalamin Substances 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- ZPTBLXKRQACLCR-XVFCMESISA-N dihydrouridine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)CC1 ZPTBLXKRQACLCR-XVFCMESISA-N 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- PSLIMVZEAPALCD-UHFFFAOYSA-N ethanol;ethoxyethane Chemical compound CCO.CCOCC PSLIMVZEAPALCD-UHFFFAOYSA-N 0.000 description 1
- 239000012847 fine chemical Substances 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- XLYOFNOQVPJJNP-ZSJDYOACSA-N heavy water Substances [2H]O[2H] XLYOFNOQVPJJNP-ZSJDYOACSA-N 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 description 1
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 125000000741 isoleucyl group Chemical group [H]N([H])C(C(C([H])([H])[H])C([H])([H])C([H])([H])[H])C(=O)O* 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- AGBQKNBQESQNJD-UHFFFAOYSA-M lipoate Chemical compound [O-]C(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-M 0.000 description 1
- 235000019136 lipoic acid Nutrition 0.000 description 1
- 238000000464 low-speed centrifugation Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 230000002906 microbiologic effect Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 229960005010 orotic acid Drugs 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N phenylalanine group Chemical group N[C@@H](CC1=CC=CC=C1)C(=O)O COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000002285 radioactive effect Effects 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 239000003998 snake venom Substances 0.000 description 1
- 229940063675 spermine Drugs 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 229960002363 thiamine pyrophosphate Drugs 0.000 description 1
- 235000008170 thiamine pyrophosphate Nutrition 0.000 description 1
- 239000011678 thiamine pyrophosphate Substances 0.000 description 1
- YXVCLPJQTZXJLH-UHFFFAOYSA-N thiamine(1+) diphosphate chloride Chemical compound [Cl-].CC1=C(CCOP(O)(=O)OP(O)(O)=O)SC=[N+]1CC1=CN=C(C)N=C1N YXVCLPJQTZXJLH-UHFFFAOYSA-N 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- 238000004809 thin layer chromatography Methods 0.000 description 1
- 229960002663 thioctic acid Drugs 0.000 description 1
- 125000003396 thiol group Chemical group [H]S* 0.000 description 1
- YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 238000000108 ultra-filtration Methods 0.000 description 1
- 238000005199 ultracentrifugation Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Enzymes And Modification Thereof (AREA)
Description
本発明は転移アール・エヌ・エー(グアノシン
−2′)メチル基転移酵素に存する。メチル基転移
酵素は、トランスメチラーゼまたはメチルトラン
スフエラーゼともいい、S−アデノシルメチオニ
ン、ベタイン、ジメチルテチン等をメチル基供与
体とし、アミノ基、ヒドロキシル基、チオール基
をメチル化する酵素であり、各種の特異的な酵素
が知られているが、転移アール・エヌ・エー(以
下において、これをtRANという)のDループ中
の5′…−G−G−…3′(Gはグアノシンを示す。
以下においても同意義を有する)のグアノシンを
特異的にメチル化する酵素は単離されていない。
本発明者等は高度好熱性細菌サーマス・サーモ
フイラス(Thermus thermophilus)から各種
の耐熱性酵素を分離精製し研究をおこなつたとこ
ろ、上述のような特異性をもつメチル基転移酵素
の単離精製に成功し、本発明に到達した。
すなわち、本発明の要旨は、
次の物理化学的性質を有する転移アール・エヌ・
エー(グアノシン−2′)メチル基転移酵素
(イ) 作用
転移アール・エヌ・エーのDループ中の5′…
−G−G−…3′(式中、Gはグアノシンを示す)
で示されるヌクレチオド配列の5′側のグアノシ
ンを、メチル基供与体の存在下に、2′−O−メ
チルグアノシンにメチル化する
(ロ) 基質特異性
Dループ中に5′…−G−G−…3′(式中、G
はグアノシンを示す)で示されるヌクレチオド
配列をもつ転移アール・エヌ・エーに作用する
(ハ) 至適PH 6.6〜7.4
(ニ) 安定PH範囲 5.5〜9.3(37℃、4時間)
(ホ) 分子量 21000(ゲル過法による)
に存する。
以下に本発明をさらに詳細に説明する。
本発明の酵素転移アール・エヌ・エー(グアノ
シン−2′)メチル基転移酵素の物理化学的性質は
次の様である。
(イ) 作用
tRNAのDループ中の5′…−G−G−…3′で
示されるヌクレチオド配列中の5′側のグアノシ
ンを、S−アデノシル−L−メチオニンのよう
なメチル基供与体の存在下に、2′−O−メチル
グアノシンにメチル化する。ここでDループと
は5′末端に一番近く常にジヒドロウリジンを含
むループを意味する。tRNAのクローバ葉型2
次構造またはL字型3次元立体構造を認識して
作用するものと考えられる。活性化剤としては
Mg++イオンが用いられる。
(ロ) 基質特異性
Dループ中に5′…−G−G−…3′で示される
ヌクレチオド配列をもつtRNAに作用する。具
体的には、酵素tRNAPhe、大腸菌tRNAMet f、仝
tRNAMet n、仝tRNAPhe、仝tRNAIle(こゝで、
Pheはフエニルアラニン、Metはメチオニン、
fはホルミル化、mは非ホルミル化、Ileはイ
ソロイシンを示す)等に対して作用しDループ
中に既にメチル化されたグアノシン、すなわち
5′…Gm−G−…3′(Gmは2′−O−メチルグア
ノシンを示す)で表わされるヌクレチオド配列
をもつtRNA、例えば大腸菌(tRNATyr(Tyr
はチロシンを示す)高度好熱性細菌の各種
tRNAは殆んどメチル化されない。
(ハ) 至適PH 6.6〜7.4
(ニ) 安定PH範囲 5.5〜9.0(37℃、4時間)
(ホ) 分子量 21000
セフアクリル(Sephacryl)S−200
(Sephacrylはフアルマシア・フアイン・ケミ
カルズ社製ゲル過剤、商標)を用いたゲル
過法による。
(ハ) 至適温度70〜72℃での活性は50℃での活性の
約5〜7倍である。
次に本発明の酵素の製造法について説明する。
本発明の酵素は、サーマス属に属する細菌の菌
体を破砕し、その破砕液から採取される。酵素源
として使用されるサーマス(Thermus)属に属
する細菌としては、サーマス・サーモフイラス
(Thermus thermophilus)が挙げられる。菌株
としてはサーマス・サーモフイラスHB27が挙げ
られる。この菌株は、工業技術院微生物工業技術
研究所に寄託されている菌株(受託番号微工研菌
寄第5160号)で、次の菌学的性質を有する。
形態:長さ3μm×巾0.5μm、桿状、胞子形成せ
ず、グラム陰性、培養状態ほとんど単細胞
コロニー:凸、円形、オレンジイエロー、径2〜
8ミリ
イーストエキス、ペブトンを含む液体培地での生
育状態:表面に薄膜が生成し、濁る。
生育温度:83℃以下
塩化ナトリウム濃度:1%まで生育
DNA:G+C=67.6〜69.6%
栄養要求性:ビチオン
生化学的性質 NO3還元:マイナス
インドールの生産:プラス
糖類からの酸およびガスの生成:
グルコース:プラス(多量)
ガラクトース:プラス(多量)
ラクトース:プラス(僅か)
シヨ糖:プラス
マルトース:プラス(多量)
デンプン:プラス
酵素の分離精製法をサーマスサーモフイラス
HB27の場合について具体的に説明すると、ま
ず、菌株を0.5%ペプトン、0.4%酵母エキス、0.2
%塩化ナトリウム、0.1%グリコースおよび0.05
%の無機塩ビタミン溶液からなる培地を使用して
80℃で5〜6時間通気培養し、300クレツト前後
で集菌し、得られた菌体を常法により、例えばア
ルミナ摩砕により破砕する。破砕液に緩衝液を加
えて抽出処理し、抽出液にウシすい臓デオキシリ
ボヌクレアーゼを加えて反応させ、上清をとり、
ジエチルアミノエチルセルロース(以下におい
て、DEAEセルロースと略す)、ホスセルロース
(以下においてP−セルロースと略す)、次いでカ
ルボキシメチル化したセフアテツクス(セフアテ
ツクスはフアルマシア社の商標、以下において、
CM−セフアデツクス)のカラムに順次通し、カ
ラムクロマトグラフイーにより分離精製する。
以上詳細に説明したように、本発明の酵素は、
tRNAのDループ中の5′…−G−G−…3′のグア
ノシンを特異的にメチル化する酵素で、このよう
な酵素が安定に分離された例はない。そしてこの
酵素は特異的な酵素試薬として、遺伝子工学、生
化学研究において、有用なものである。
以下において実施例によりさらに詳細に説明す
る。なお、実施例中A260は、260nmでの吸光度で
ある。
実施例 1
(1) サーマスサーモフイラスHB27の培養
サーマスサーモフイラスHB27を0.5%ペプト
ン、0.4%酵母エキス、0.2%塩化ナトリウム、
0.1%グルコース及び0.05%の無機塩ビタミン
溶液(水1中に25gMgCl2・6H2O、5g
CaCl2、2gMnSO4・6H2O、0.5gZnSO4・
7H2O、0.5gH3BO3、5gFeCl3・6H2O、15
mgCuSO4、25gNaMoO4・2H2O、50mg
CoNO3・6H2O、20mgNiNO3・6H2O、80mgピ
リドキサン、10mg葉酸、0.5mlH2SO4、10mgチ
アミンピロリン酸、40mgリボフラビン、80mgニ
コチンアミド、80mgパラアミノ安息香酸、10mg
ビチオン、0.4mgシアノコバラミン、80mgパン
トテイン酸、20mgリポ酸、200mgイノシトール、
50mgコリン、50mgオロチン酸、100mgスペルミ
ンを含む)を含む培地を用いて、80℃で5〜6
時間通気培養し、300クレツト前後で集菌した。
80から約400gのHB27の菌体を得ることが
できた。
(2) 酵素の分離、精製
すべての操作は4℃でおこなつた。
(A) 酵素の抽出
以上のように得られたHB27の菌体約1Kg
に等量のアルミナを加えて約1時間磨砕し
た。これに、2の標準緩衝液(0.01M、
Tris−HCl(PH7.5)−0.01M MgCl2−0.05M
KCl−6mMβ−メルカプトエタノール、以下
においても同じ組成を示す)を加えて酵素を
抽出した。抽出液は10000g20分の遠心でア
ルミナ、細胞残渣の沈殿と上清とに分け、沈
殿は再び1の標準緩衝液で抽出後、遠心分
離し上清を取得した。2回の遠心による上清
を合せて、ウシすい臓デオキシリボヌクレア
ーゼを1μg/ml加えて15分放置した。この
溶液を105000g3時間超遠心を行ない、得ら
れた上清を粗酵素抽出液(2.5)とした。
(B) DEAE−セルロースカラムクロマトグラフ
イー
(A)で得られた粗酵素液に硫安を80%飽和に
まで加え、一晩放置後、10000g30分の遠心
で生成した沈殿を集めた。この沈殿をできる
限り少量の標準緩衝液に溶解して、同じ緩衝
液に対して一晩透析を行なつた。この透析し
た酵素溶液(1.3)を、同じ標準緩衝液で
平衡化したDEAE−セルロースのカラム
(5.2×54.5cm)に添加し、標準緩衝液で展開
した。このカラムの未吸着分画にtRNA(グ
アノシン−2′)メチル基転移酵素は含まれ
る。
なお、酵素活性の測定は、以下のようにし
ておこなつた。
基質として大腸菌未分画tRNA、メチル基
供与体としてはS−アデノシル−L−メチオ
ニンを用いる。酵素反応は、80μの0.01M
Tris−HCl(PH7.5)、0.01M MgCl2、5mMア
デノシントリリン酸、6mMβ−メルカプトエ
タノール、0.4OD260単位の大腸菌未分画
tRNA、8.1μM S−アデノシル−L−〔メチ
ル−14C〕−メチオニン(62Ci/mole)を含む
溶液に、20μの酵素溶液を添加して行な
う。65℃で30分加温後、80μの反応溶液を
分取し、これを、2.5cmの円型ロ紙につけ、
しみこんだ所で、氷冷した5%トリクロロ酢
酸につけて、3回洗浄し、その後、エタノー
ル−エーテル(1:1v/v)、エーテルで順
次洗う。乾燥後紙上に残つた放射活性を液
体シチレーシヨンカウンターで測定する。
この条件下で、1時間に1nmoleのメチル
基を転移し得る酵素量を1単位と定義した。
(C) P−セルロースカラムクロマトグラフイー
(B)のDEAE−セルロースカラムクロマトグ
ラフイーにおける未吸着画分を直接、やはり
標準緩衝液で平衡化したP−セルロースのカ
ラム(3.5×39.5cm)に添加するとメチル基
転移酵素は、このカラムに吸着された。標準
緩衝液で洗浄後、KCl濃度、0.05Mから0.8M
の直線濃度勾配(2)で溶出を行なつた。
メチル基転移酵素活性は、KCl濃度0.44M〜
0.54Mの分画(分画という)に小さいピー
クが、KCl濃度0.64M〜0.79Mの分画(分画
という)に大きいピークが表われ、2つの
分画に分離するが、分画がtRNA(グアノ
シン−2′)メチル基転移酵素活性に対応して
いる。ここでの酵素液(分画)は275mlで、
酵素量は2358単位であつた。
(D) CM−セフアデツクスC−50(セフアデツ
クスは商標)カラムクロマトグラフイー
(C)で得られたtRNA(グアノシン−2′)メ
チル基転移酵素分画275mlをDiaflo PM−10
(Diafloは商標、アミコン社製)の膜で限外
過を行ない75mlにまで濃縮した。この溶液
を0.01M Tris−HCl(PH7.5)−0.01M MgCl2
−0.1M KCl−6mM βメルカプトエタノー
ルの緩衝液に対して透析した。生成した沈殿
を低速遠心で除き、その上清を同じ緩衝液で
平衡化したCM−Sephdex C−50のカラム
(1.57×23.5cm)に添加し、KCl濃度0.1Mか
ら0.5Mの直線濃度勾配(400ml)で溶出を行
なうとメチル基転移酵素はA260のピークとほ
ぼ一致して対称性の良いピークで溶出され
た。ピーク位置は、KCl濃度で0.26〜0.31M
であつた。
得られたメチル基転移酵素液は59mlでは、
酵素量は1610単位であつた。
(3) 酵素の性質の測定
(2)の(D)で得られた酵素液を用いて測定した。
(A) 至適PH、安定PH範囲、至適温度
至適PHは6.6〜7.4で、37℃4時間処理した
ときの安定PH範囲は5.5〜9.0であり、70℃〜
72℃での活性は50℃での活性の約5〜7倍で
あつた。
(B) 基質特異性、作用
(a) ヌクレチオドについての特異性
大腸菌未分画tRNAは良い基質となる
が、このtRNAをメチル化後リボヌクレア
ーゼT2で完全分解して2次元の薄層クロ
マトグラフイーでメチル化ヌクレチオドを
分析するとGm Gp(ここではGmは2′−O
−メチルグアノシン、Gpはグアノシンを
示す)の位置にのみ放射活性が見いださ
れ、この酵素は5′…−G−G−…3′という
ヌクレチオド配列の5′側のグアノシンを
2′−O−メチルグアノシンにメチル化する
ことが示された。
(b) 大腸菌tRNAMet fにおけるメチル化部位
大腸菌tRNAMet fは、ヌクレチオド配列が
決定されており、2′−O−メチルグアノシ
ンは含まれていない。メチル化tRNAMet fの
リボヌクレアーゼT2分解物を分析すると
(a)と同様にGm Gpが生成していた。次に
リボヌクレアーゼT1で完全分解後、7M尿
素の存在下DEAE−セフアデツクスA−25
でオリゴヌクレチオドを分画すると未修飾
大腸菌tRNAMet fのリボヌクレアーゼT1分
解物には見られないペンタヌクレチオドが
検出され、放射活性のピークと一致した。
この放射活性を持つペンタヌクレチオド
を、ヘビ毒、ホスホジエステラーゼ及び大
腸菌ホスホモノエステラーゼでヌクレチオ
ドにまで分解後高速液体クロマトグラフイ
ーで分析した。C、U、Gm、Gが2.1:
0.78:0.75:1.0(リボヌクレアーゼT1分解
物なのでGを1.0モルとして計算)のモル
比で検出され放射活性はGmの所にのみ存
在した。このことからメチル化部位は
(C、C、U)Gm Gpなるペンタヌクレチ
オドであることが判明した。大腸菌
tRNAMet fの構造から考えて、この様なヌク
レチオド組成を持つ可能性のあるのは、
CCU Gm Gpだけであるので、この酵素
によるメチル化部位は5′−末端から19番目
にある、Dループ中のG19のリボースであ
ることが結論された。これは、高度好熱菌
のtRNAMet fで見られたメチル化部位と同じ
である。
(C) 各種アミノ酸特異tRNAに対する活性
(2)の(B)に記載した酵素活性の測定の条件下
で、第1表に示した。酵母、大腸菌、高度好
熱菌のtRNAの0.10〜0.14A260単位を、(2)の
(D)で得られた酵素0.21単位でメチル化をおこ
なつた。その結果を第1表に示す。
(C)セフアクリル(Sephacryl)S−200を
用いたゲル過法により測定した分子量は
21000であつた。
The present invention resides in TransferRNA (guanosine-2') methyltransferase. Methyltransferase is also called transmethylase or methyltransferase, and is an enzyme that methylates amino groups, hydroxyl groups, and thiol groups using S-adenosylmethionine, betaine, dimethyltetine, etc. as a methyl group donor. Various specific enzymes are known, but 5'...-G-G-...3' (G represents guanosine) in the D loop of Transfer RNA (hereinafter referred to as tRAN) .
An enzyme that specifically methylates guanosine (which has the same meaning below) has not been isolated. The present inventors isolated and purified various thermostable enzymes from the highly thermophilic bacterium Thermus thermophilus , and conducted research. We succeeded and arrived at the present invention. That is, the gist of the present invention is to provide a transition R.N.
A (guanosine-2') methyltransferase (A) Action: 5' in the D loop of RA...
-G-G-...3' (in the formula, G represents guanosine)
The guanosine on the 5' side of the nucleotide sequence shown is methylated to 2'-O-methylguanosine in the presence of a methyl group donor (b) Substrate specificity 5'...-G-G in the D-loop −…3′ (in the formula, G
(denotes guanosine)) Acts on the transition RNA with the nucleotide sequence shown by (c) Optimum pH 6.6-7.4 (d) Stable pH range 5.5-9.3 (37℃, 4 hours) (e) Molecular weight 21000 (by gel filtration method). The present invention will be explained in more detail below. The physicochemical properties of the enzymatic transfer RA (guanosine-2') methyltransferase of the present invention are as follows. (b) Effect The guanosine on the 5' side of the nucleotide sequence shown by 5'...-G-G-...3' in the D-loop of tRNA is treated with a methyl group donor such as S-adenosyl-L-methionine. methylation to 2'-O-methylguanosine. Here, the D-loop means the loop closest to the 5' end and always containing dihydrouridine. tRNA cloverleaf type 2
It is thought that it acts by recognizing the following structure or L-shaped three-dimensional structure. As an activator
Mg ++ ions are used. (b) Substrate specificity Acts on tRNA that has the nucleotide sequence 5'...-GG-...3' in the D-loop. Specifically, the enzyme tRNA Phe , Escherichia coli tRNA Met f ,
tRNA Met n , tRNA Phe , tRNA Ile (here,
Phe is phenylalanine, Met is methionine,
f is formylated, m is non-formylated, Ile is isoleucine), etc., and acts on guanosine that is already methylated in the D loop, i.e.
5'...Gm-G-...3' (Gm indicates 2'-O-methylguanosine) tRNA with a nucleotide sequence, such as E. coli (tRNA Tyr (Tyr
indicates tyrosine) Various types of highly thermophilic bacteria
tRNA is rarely methylated. (c) Optimal PH 6.6-7.4 (d) Stable PH range 5.5-9.0 (37℃, 4 hours) (e) Molecular weight 21000 Sephacryl S-200
(Sephacryl is a gel filtration agent manufactured by Pharmacia Fine Chemicals, trademark) by a gel filtration method. (c) The activity at the optimum temperature of 70 to 72°C is about 5 to 7 times that at 50°C. Next, the method for producing the enzyme of the present invention will be explained. The enzyme of the present invention is obtained by crushing the cells of a bacterium belonging to the genus Thermus and collecting the crushed liquid. Bacteria belonging to the genus Thermus used as an enzyme source include Thermus thermophilus . The strain includes Thermus thermophilus HB27. This strain has been deposited with the Institute of Microbial Technology, Agency of Industrial Science and Technology (Accession number: Microbiological Research Institute No. 5160), and has the following mycological properties. Morphology: Length 3 μm x Width 0.5 μm, rod-shaped, non-sporulating, Gram negative, culture state Almost single-cell colony: convex, circular, orange-yellow, diameter 2~
Growth status in liquid medium containing 8mm yeast extract and pebtone: A thin film forms on the surface and becomes cloudy. Growth temperature: below 83°C Sodium chloride concentration: Growth up to 1% DNA: G+C = 67.6-69.6% Auxotrophy: Bithion biochemical properties NO 3 reduction: Minus production of indole: Plus production of acid and gas from sugars: Glucose: Plus (large amount) Galactose: Plus (large amount) Lactose: Plus (slight amount) Sugar: Plus Maltose: Plus (large amount) Starch: Plus Enzyme separation and purification method Thermus Thermophilus
To explain specifically the case of HB27, first, the strain was mixed with 0.5% peptone, 0.4% yeast extract, and 0.2% yeast extract.
% sodium chloride, 0.1% glycose and 0.05
Using a medium consisting of % inorganic salt vitamin solution
The cells are aerated at 80° C. for 5 to 6 hours, collected at around 300 ml, and the resulting cells are crushed by a conventional method, for example, by alumina grinding. A buffer solution is added to the crushed solution for extraction treatment, bovine pancreatic deoxyribonuclease is added to the extract and reacted, and the supernatant is taken.
Diethylaminoethyl cellulose (hereinafter abbreviated as DEAE cellulose), Phoscellulose (hereinafter abbreviated as P-cellulose), then carboxymethylated Cefatex (Sefatex is a trademark of Pharmacia, hereinafter,
The mixture is sequentially passed through a column of CM-Sephadex) and separated and purified by column chromatography. As explained in detail above, the enzyme of the present invention is
There is no example of an enzyme that specifically methylates the 5'...-GG-...3' guanosine in the D-loop of tRNA, and such an enzyme has been stably isolated. This enzyme is useful as a specific enzyme reagent in genetic engineering and biochemical research. This will be explained in more detail by way of examples below. In addition, A260 in Examples is the absorbance at 260 nm. Example 1 (1) Cultivation of Thermus thermophilus HB27 Thermus thermophilus HB27 was grown in 0.5% peptone, 0.4% yeast extract, 0.2% sodium chloride,
0.1% glucose and 0.05% inorganic salt vitamin solution (25 g MgCl 2 6H 2 O, 5 g in 1 water
CaCl2 , 2gMnSO4・6H2O , 0.5gZnSO4・
7H2O , 0.5gH3BO3 , 5gFeCl3・6H2O , 15
mgCuSO4 , 25gNaMoO4・2H2O , 50mg
CoNO3・6H2O , 20mgNiNO3・6H2O , 80mg pyridoxane, 10mg folic acid, 0.5mlH2SO4 , 10mg thiamine pyrophosphate, 40mg riboflavin, 80mg nicotinamide, 80mg para-aminobenzoic acid, 10mg
Bithion, 0.4mg cyanocobalamin, 80mg pantotheic acid, 20mg lipoic acid, 200mg inositol,
5-6 at 80℃ using a medium containing 50mg choline, 50mg orotic acid, 100mg spermine).
The cells were aerated and cultured for an hour, and the bacteria were collected after about 300 hours.
We were able to obtain 80 to approximately 400 g of HB27 bacterial cells. (2) Enzyme separation and purification All operations were performed at 4°C. (A) Enzyme extraction Approximately 1 kg of HB27 bacterial cells obtained as above
An equal amount of alumina was added to the mixture and ground for about 1 hour. To this, add 2 standard buffers (0.01M,
Tris−HCl (PH7.5) −0.01M MgCl 2 −0.05M
The enzyme was extracted by adding KCl-6mM β-mercaptoethanol (same composition shown below). The extract was centrifuged at 10,000 g for 20 minutes to separate the alumina and cell debris into a precipitate and a supernatant, and the precipitate was extracted again with standard buffer 1 and centrifuged to obtain a supernatant. The supernatants from the two centrifugations were combined, 1 μg/ml of bovine pancreatic deoxyribonuclease was added, and the mixture was left for 15 minutes. This solution was subjected to ultracentrifugation at 105,000 g for 3 hours, and the resulting supernatant was used as a crude enzyme extract (2.5). (B) DEAE-Cellulose Column Chromatography Ammonium sulfate was added to the crude enzyme solution obtained in (A) to 80% saturation, left overnight, and centrifuged at 10,000 g for 30 minutes to collect the resulting precipitate. This precipitate was dissolved in as small a volume of standard buffer as possible and dialyzed overnight against the same buffer. This dialyzed enzyme solution (1.3) was added to a DEAE-cellulose column (5.2 x 54.5 cm) equilibrated with the same standard buffer and developed with the standard buffer. The unadsorbed fraction of this column contains tRNA (guanosine-2') methyltransferase. The enzyme activity was measured as follows. E. coli unfractionated tRNA is used as a substrate, and S-adenosyl-L-methionine is used as a methyl group donor. Enzyme reaction 80μ 0.01M
Tris-HCl (PH7.5), 0.01M MgCl2 , 5mM adenosine triphosphate, 6mM β-mercaptoethanol, 0.4OD 260 units of unfractionated E. coli
The test is carried out by adding 20μ of enzyme solution to a solution containing tRNA and 8.1μM S-adenosyl-L-[methyl- 14C ]-methionine (62Ci/mole). After heating at 65℃ for 30 minutes, collect 80μ of the reaction solution and apply it to a 2.5cm circular paper.
Once soaked, wash three times with ice-cold 5% trichloroacetic acid, then sequentially with ethanol-ether (1:1 v/v) and ether. After drying, the radioactivity remaining on the paper is measured using a liquid stillation counter. Under these conditions, the amount of enzyme capable of transferring 1 nmole of methyl groups per hour was defined as 1 unit. (C) P-cellulose column chromatography The unadsorbed fraction from the DEAE-cellulose column chromatography in (B) was directly added to a P-cellulose column (3.5 x 39.5 cm) that had also been equilibrated with standard buffer. The methyltransferase was then adsorbed onto this column. After washing with standard buffer, KCl concentration, 0.05M to 0.8M
Elution was performed with a linear concentration gradient (2) of
Methyltransferase activity is measured at KCl concentration of 0.44M~
A small peak appears in the 0.54M fraction (referred to as fractionation), and a large peak appears in the KCl concentration 0.64M to 0.79M fraction (referred to as fractionation), and the fraction is separated into two fractions, but the fraction is tRNA. (guanosine-2') methyltransferase activity. The enzyme solution (fraction) used here is 275ml.
The amount of enzyme was 2358 units. (D) CM-Sephadex C-50 (Sephadex is a trademark) column chromatography 275 ml of the tRNA (guanosine-2') methyltransferase fraction obtained in (C) was transferred to Diaflo PM-10.
(Diaflo is a trademark, manufactured by Amicon) membrane was subjected to ultrafiltration and concentrated to 75 ml. This solution was mixed with 0.01M Tris−HCl (PH7.5)−0.01M MgCl2
Dialysis was performed against a buffer of -0.1M KCl-6mM β-mercaptoethanol. The generated precipitate was removed by low-speed centrifugation, and the supernatant was applied to a CM-Sephdex C-50 column (1.57 x 23.5 cm) equilibrated with the same buffer solution, and a linear concentration gradient (KCl concentration of 0.1M to 0.5M) was applied. When elution was carried out with 400ml), the methyltransferase was eluted as a well-symmetrical peak that almost coincided with the A260 peak. The peak position is 0.26-0.31M in KCl concentration
It was hot. The obtained methyltransferase solution is 59ml.
The amount of enzyme was 1610 units. (3) Measurement of enzyme properties Measurements were made using the enzyme solution obtained in (D) of (2). (A) Optimal PH, stable PH range, optimal temperature The optimal PH is 6.6 to 7.4, and the stable PH range when treated for 4 hours at 37℃ is 5.5 to 9.0, and the stable PH range is 5.5 to 9.0, and the stable PH range is 5.5 to 9.0, and the stable PH range is 5.5 to 9.0 when treated at 37℃ for 4 hours.
The activity at 72°C was about 5 to 7 times that at 50°C. (B) Substrate specificity, action (a) Specificity for nucleotides Escherichia coli unfractionated tRNA is a good substrate, but after methylation, this tRNA is completely degraded with ribonuclease T 2 and subjected to two-dimensional thin layer chromatography. When the methylated nucleotide is analyzed with Gm Gp (here Gm is 2′-O
-Methylguanosine, Gp indicates guanosine), and this enzyme detects guanosine on the 5' side of the 5'...-G-G-...3' nucleotide sequence.
It was shown that methylation occurs to 2'-O-methylguanosine. (b) Methylation site in E. coli tRNA Met f The nucleotide sequence of E. coli tRNA Met f has been determined, and it does not contain 2'-O-methylguanosine. Analysis of ribonuclease T2 degradation products of methylated tRNA Met f
As in (a), Gm Gp was generated. Next, after complete digestion with ribonuclease T1 , DEAE-Sephadex A-25 was dissolved in the presence of 7M urea.
When the oligonucleotides were fractionated, a pentanucleotide that was not found in the ribonuclease T 1- digested product of unmodified E. coli tRNA Met f was detected, which coincided with the peak of radioactivity.
This radioactive pentanucleotide was degraded into nucleotides using snake venom, phosphodiesterase, and Escherichia coli phosphomonoesterase, and then analyzed using high performance liquid chromatography. C, U, Gm, G are 2.1:
It was detected at a molar ratio of 0.78:0.75:1.0 (calculated assuming G as 1.0 mol since it is a ribonuclease T1 degradation product), and radioactivity was present only at Gm. This revealed that the methylation site was a pentanucleotide (C, C, U) Gm Gp. Escherichia coli
Considering the structure of tRNA Met f , it is possible that it has such a nucleotide composition.
Since there is only CCU Gm Gp, it was concluded that the methylation site by this enzyme is the G19 ribose in the D loop, which is located at the 19th position from the 5'-end. This is the same methylation site found in tRNA Met f of extreme thermophiles. (C) Activity against various amino acid-specific tRNAs The enzyme activity was measured under the conditions described in (2) (B) as shown in Table 1. 0.10-0.14A 260 units of tRNA from yeast, Escherichia coli, and hyperthermophilic bacteria were added to (2).
Methylation was performed using 0.21 units of the enzyme obtained in (D). The results are shown in Table 1. (C) Molecular weight measured by gel filtration method using Sephacryl S-200
It was 21000.
【表】【table】
【表】
第1表から明らかなように酵母tRNAPhe、大腸
菌tRNAMet f、tRNAMet n、tRNAPhe、tRNAIleは良
い基質となる。一方、Dループ中に既に…Gm
Gp…と言う修飾部位を持つ大腸菌tRNATyr、高
度好熱菌の各種tRNAは、ほとんどメチル化され
ない。
以上本酵素はtRNAのDループ中の5′…−G−
G−…3′という配列に特異的なメチル基転移酵素
であるということが判る。つまりtRNAのクロー
バ型2次構造はL字型3次元立体構造を認識して
いると思われる。これは生体内でのこの酵素の役
割はtRNAをメチル化することにあると考えられ
る。[Table] As is clear from Table 1, yeast tRNA Phe , E. coli tRNA Met f , tRNA Met n , tRNA Phe , and tRNA Ile are good substrates. Meanwhile, during the D loop...Gm
Escherichia coli tRNA Tyr and various tRNAs of extreme thermophiles, which have a modification site called Gp, are hardly methylated. As mentioned above, this enzyme is 5'...-G- in the D loop of tRNA.
It turns out that it is a methyltransferase specific to the sequence G-...3'. In other words, the cloverleaf-shaped secondary structure of tRNA seems to recognize the L-shaped three-dimensional structure. This suggests that the role of this enzyme in vivo is to methylate tRNA.
Claims (1)
ヌ・エー(グアノシン−2′)メチル基転移酵素。 (イ) 作用 転移アール・エヌ・エーのDループ中の5′…
−G−G−…3′(式中、Gはグアノシンを示す)
で示されるヌクレオチド配列の5′側のグアノシ
ンを、メチル基供与体の存在下に、2′−0−メ
チルグアノシンにメチル化する (ロ) 基質特異性 Dループ中に5′…−G−G−…3′(式中、G
はグアノシンを示す)で示されるヌクレチオド
配列をもつ転移アール・エヌ・エーに作用する (ハ) 至適PH 6.6〜7.4 (ニ) 安定PH範囲 5.5〜9.0(37℃、4時間) (ホ) 分子量 21000(ゲル過法による)[Scope of Claims] A transfer RA (guanosine-2') methyltransferase having the following physicochemical properties: (a) Effect: 5′ in the D loop of the transfer RNA...
-G-G-...3' (in the formula, G represents guanosine)
The guanosine on the 5' side of the nucleotide sequence shown by is methylated to 2'-0-methylguanosine in the presence of a methyl group donor (b) Substrate specificity 5'...-G-G in the D-loop −…3′ (in the formula, G
(indicates guanosine)) Acts on the transition RNA with the nucleotide sequence shown by (c) Optimum pH 6.6-7.4 (d) Stable pH range 5.5-9.0 (37℃, 4 hours) (e) Molecular weight 21000 (by gel filtration method)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP10770879A JPS5632990A (en) | 1979-08-24 | 1979-08-24 | T-ran (guanosine-2') metahyl transferase |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP10770879A JPS5632990A (en) | 1979-08-24 | 1979-08-24 | T-ran (guanosine-2') metahyl transferase |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS5632990A JPS5632990A (en) | 1981-04-02 |
JPS6317434B2 true JPS6317434B2 (en) | 1988-04-13 |
Family
ID=14465927
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP10770879A Granted JPS5632990A (en) | 1979-08-24 | 1979-08-24 | T-ran (guanosine-2') metahyl transferase |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS5632990A (en) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH01203932A (en) * | 1988-02-10 | 1989-08-16 | Fujikura Ltd | Liquid detection sensor |
JPH01203933A (en) * | 1988-02-10 | 1989-08-16 | Fujikura Ltd | Liquid detection sensor |
JPH0277651U (en) * | 1988-11-30 | 1990-06-14 | ||
JPH05500414A (en) * | 1989-06-15 | 1993-01-28 | システムズ・ケミストリイ・インコーポレーテッド | Fluid control valves and systems with leak detection and containment |
JPH0745094U (en) * | 1991-02-12 | 1995-12-19 | システムズ・ケミストリイ・インコーポレーテッド | Connection structure for fluid treatment equipment |
KR20180127517A (en) * | 2017-04-10 | 2018-11-28 | 미쓰이 가가쿠 가부시키가이샤 | A xylylene diisocyanate composition, a xylylene diisocyanate modifier composition, a two-component resin raw material and a resin |
KR20220025083A (en) * | 2017-04-10 | 2022-03-03 | 미쓰이 가가쿠 가부시키가이샤 | Xylylene diisocyanate composition, xylylene diisocyanate modification composition, two-component resin starting material, and resin |
-
1979
- 1979-08-24 JP JP10770879A patent/JPS5632990A/en active Granted
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH01203932A (en) * | 1988-02-10 | 1989-08-16 | Fujikura Ltd | Liquid detection sensor |
JPH01203933A (en) * | 1988-02-10 | 1989-08-16 | Fujikura Ltd | Liquid detection sensor |
JPH0277651U (en) * | 1988-11-30 | 1990-06-14 | ||
JPH05500414A (en) * | 1989-06-15 | 1993-01-28 | システムズ・ケミストリイ・インコーポレーテッド | Fluid control valves and systems with leak detection and containment |
JPH0745094U (en) * | 1991-02-12 | 1995-12-19 | システムズ・ケミストリイ・インコーポレーテッド | Connection structure for fluid treatment equipment |
KR20180127517A (en) * | 2017-04-10 | 2018-11-28 | 미쓰이 가가쿠 가부시키가이샤 | A xylylene diisocyanate composition, a xylylene diisocyanate modifier composition, a two-component resin raw material and a resin |
KR20220025083A (en) * | 2017-04-10 | 2022-03-03 | 미쓰이 가가쿠 가부시키가이샤 | Xylylene diisocyanate composition, xylylene diisocyanate modification composition, two-component resin starting material, and resin |
Also Published As
Publication number | Publication date |
---|---|
JPS5632990A (en) | 1981-04-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Sugimura | Poly (adenosine diphosphate ribose) | |
EP0857788B1 (en) | Method for producing nucleoside-5'-phosphate ester | |
EP0832970B1 (en) | Process for producing nucleoside-5'-phosphate ester | |
Mandel et al. | The nature of the RNA synthesized during conditions of unbalanced growth in E. coli K12W-6 | |
Bresnick | Feedback inhibition of aspartate transcarbamylase in liver and in hepatoma | |
Kumagai et al. | Thermally induced biosynthesis of 2'-O-methylguanosine in tRNA from an extreme thermophile, Thermus thermophilus HB27. | |
August et al. | Replication of RNA viruses: I. Characterization of a viral RNA-dependent RNA polymerase | |
Brent | Properties of a human lymphoblast AP-endonuclease associated with activity for DNA damaged by ultraviolet light,. gamma.-rays, or osmium tetroxide | |
JPS6317434B2 (en) | ||
Williams et al. | A mollicute (mycoplasma) DNA repair enzyme: purification and characterization of uracil-DNA glycosylase | |
Warner et al. | Incorporation and excision of 5-fluorouracil from deoxyribonucleic acid in Escherichia coli | |
JP2795748B2 (en) | Method for producing nucleoside | |
Goulian et al. | Properties of oligodeoxynucleotides that determine priming activity with Escherichia coli deoxyribonucleic acid polymerase I | |
JP3369236B2 (en) | Method for producing choline cytidine diphosphate | |
Devash et al. | Plant oligoadenylates: enzymic synthesis, isolation, and biological activities | |
JP3764755B2 (en) | "Production Method of Adenosine 5'-Triphosphate and Its Application" | |
Merola et al. | Preparation and properties of soybean ribonuclease | |
Irie | pH-Profiles of the Kinetic Parameters of Ribonuclease from Aspergillus saitoi | |
JPS6111598B2 (en) | ||
JPS6341559B2 (en) | ||
Whitehead et al. | Restriction endonucleases from Herpetosiphon giganteus: an example of the evolution of DNA recognition specificity? | |
JPS60156388A (en) | Dna and its use | |
JPS6331193B2 (en) | ||
JP4173815B2 (en) | Method for producing 2'-deoxyguanosine | |
Yamazaki et al. | Substrate specificity of tRNA (adenine-1-)-methyltransferase from Thermus thermophilus HB27 |